• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Orient EuroPharma - Articles and news items

Asian licensing deals for Ergomed and Aeterna Zentaris’ endometrial cancer drug

Industry news / 6 September 2016 / Niamh Louise Marriott, Digital Content Producer

Aeterna Zentaris signed an exclusive license agreement with affiliates of Orient EuroPharma for its lead anti-cancer compound, zoptrex, for the initial…

 

Webinar: NIR Spectroscopy for Assessing Blend Uniformity in the Pharmaceutical IndustryLEARN MORE
+ +